ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

EuroStoxx 50 slides 0.8% as oil price rise fuels inflation fears

The Euro Stoxx 50 fell to 6,368.98, its lowest since early August, as higher oil prices and heightened Iran tensions revived inflation concerns and expectations of an ECB rate hike. Swiss and UK indices also moved modestly.

PA
Priya Anand · Equities & Earnings Desk · 13 Sept 2026 · 05:21 · 1 min read
Share
EuroStoxx 50 slides 0.8% as oil price rise fuels inflation fears

The Euro Stoxx 50 extended its early‑week losses on Tuesday, slipping 0.80% to 6,368.98 points, a level last seen at the start of August. Outside the euro area, Switzerland's SMI rose 0.34% to 14,334.79 points, while the UK FTSE 100 closed 0.32% lower at 10,789.28.

Analysts linked the decline to a fresh surge in oil prices and the escalating conflict in Iran, which revived inflation anxieties and revived expectations of a European Central Bank (ECB) rate hike next week. Eurostat reported that euro‑zone consumer prices rose 3.3% year‑on‑year in August, driven by higher energy costs.

"Investors are slowly realizing that the end of the rate‑adjustment cycle is not yet in sight," said Jochen Stanzl of Consorsbank. Thomas Gitzel of VP Bank added that the ECB is likely to interpret the inflation data as a mandate for a tightening move. In the United States, former Fed official Kevin Warsh reiterated the Fed’s resolve to curb inflation, keeping a September rate hike on the table.

Oil‑related stocks led the sectoral winners, with the oil group gaining 1.8%. Eni climbed 1.5% and TotalEnergies posted the biggest gain in the Euro Stoxx, up 2.8%. By contrast, the airline and travel sector lagged, slipping 2.3% as higher fuel costs and geopolitical risk weighed on sentiment.

Individual equities showed mixed moves. Air Liquide rose about 2% after reports that activist investor Elliott had taken a stake and was urging management to improve margins. Novartis surged more than 6% following a positive multiple‑sclerosis study of its experimental drug remibrutinib. Partners Group Holding fell roughly 7% after disappointing quarterly figures and an unexpected change at the top of its management team.

Overall, the market’s reaction underscored the sensitivity of European equities to energy price dynamics, inflation data and the prospect of tighter monetary policy across the region.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT
EuroStoxx 50 drops 0.8% on oil price rise · Finance Review Daily